Navigation Links
Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Date:11/6/2008

663.

About Alexza Pharmaceuticals

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Alexza has five product candidates in clinical development. Alexza's lead program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic or bipolar disorder patients, has completed one Phase 3 clinical trial and enrolled a second Phase 3 trial. The Company has completed its end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), which is intended for the acute treatment of migraine headache, and it has advanced AZ-104 (Staccato loxapine) to Phase 2 testing. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with Endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. In addition, AZ-002 (Staccato alprazolam) has completed a Phase 2a proof-of-concept clinical trial for the treatment of panic attacks -- an indication the Company is not planning to pursue -- and is being assessed for other possible indications and renewed clinical development. More information, including this and past press releases from Alexza, is available online at http://www.alexza.com.

Safe Harbor Statement

Alexza's policy is to only provide guidance on product candidates and corporate goals for the future one to
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
2. Alexza and Autoliv Announce Commercial Manufacturing and Supply Agreement for Heat Packages Used in Single-Dose Staccato(R) System
3. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 28th Annual Health Care Conference
4. Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
5. Alexza to Webcast Investor and Analyst Day Presentations
6. Alexzas Corporate Presentation to be Webcast at the Seventh Annual JMP Securities Research Conference and the 2008 Citi Investment Research Global Healthcare Conference
7. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
8. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
9. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
10. Alexza to Announce 2008 Third Quarter Financial Results and Update Its Clinical Pipeline on Thursday, November 6, 2008
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... My Clients Plus ( http://www.MyClientsPlus.com ) ... therapy note templates. Healthcare providers can now create ... all while meeting the HIPPA security requirements.     , ... (EMR) consist of psychological intake forms, treatment plan ... SOAP and DAP note formats are also available. ...
(Date:7/30/2014)... Regents Health Resources, a consulting firm ... health care industry veteran Daryl Demonbreun and former St. ... the company’s ambitious plans to grow into a full-service ... moving along at a steady pace for nearly 20 ... notch,” says Bob Maier, founder and chief executive officer ...
(Date:7/29/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and retailer, ... . Aside from this, it has announced that all of ... off. All of its old and new clients may now ... says excitedly, “We are pleased to release the new collection ... a lot of amazing items. It is true that our ...
(Date:7/29/2014)... 2014 Dignity Sciences Limited, a privately ... a Phase I trial with DS107G, an oral formulation ... was a randomized, placebo-controlled, double-blind, single-ascending and multiple dose ... and effect of food on DS107G in healthy subjects. ... of DGLA following both single and multiple oral doses ...
(Date:7/29/2014)... they have discovered a chemical alteration in a single ... in larger studies, could give doctors a simple blood ... suicide. , The discovery, described online in The ... a gene involved in the function of the brain,s ... turning what might otherwise be an unremarkable reaction to ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces Over 80 Online Therapy Notes to Help Healthcare Providers Go Paperless 2Health News:Sferrella and Demonbreun Join Regents Health Resources 2Health News:Cheap Satin Bridal Gowns Recently Provided By Well-known Supplier iFitDress.com 2Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3
... chicks to gardens, Oxfam America Unwrapped offers unique,gifts for ... gift-givers,are faced with the same dilemma: What to get ... gift that comes from you on Mother,s Day.,This year, ... the,perfect gift and make a difference for communities in ...
... Washington, D.C. and Virginia Provided Access to Educational ... ... The American Heart Association and,Comcast have partnered to raise ... by making stroke awareness-related programming,available through Comcast,s ON DEMAND service. ...
... Work to Educate Adult Caregivers, WASHINGTON, May ... Relations Worldwide (Ogilvy PR), an integrated,global communications firm, ... $1.4,million dollar contract from the Centers for Medicare ... with CMS in its efforts to directly communicate,with ...
... in retail,industrial and financial service industries, SAN ... the impact of health-related absence to their bottom ... "The Business,Response of Employers to Absence." The research ... employers, across a variety of,industries and operating models. ...
... yogurt flavors to ... satisfy consumers, hungry demands, LONDONDERRY, N.H., May 5 ... flavor offerings of its,organic, authentically strained Greek yogurt, Oikos Organic. ... line of,0% fat favorites, Vanilla and Plain. Oikos Organic is ...
... 2008 While MRSA has been an issue in ... have been on the rise, with the greatest risk ... teams, at schools and daycare centers. In May, The ... Cleaner, a disinfectant that is EPA registered to kill ...
Cached Medicine News:Health News:This Mother's Day, Surprise Mom With a New Way to Give 2Health News:The American Heart Association and Comcast Team Up to Strike Out Stroke 2Health News:The American Heart Association and Comcast Team Up to Strike Out Stroke 3Health News:Centers for Medicare & Medicaid Services Awards Ogilvy Public Relations Worldwide $1.4 Million Dollar Contract 2Health News:Integrated Benefits Institute Releases Research on True Cost of Absence for Employers 2Health News:Oikos Organic Greek Yogurt Ventures into the Land of Milk and Honey ... and Blueberry! 2Health News:Oikos Organic Greek Yogurt Ventures into the Land of Milk and Honey ... and Blueberry! 3
(Date:7/29/2014)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... 2014 Clinical Lab Expo today by unveiling two booths ... is partnering with customers to redefine the value of ... day that they,re looking for a partner to help ... and offices," said Jack Phillips , president and ...
(Date:7/29/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... device is a medical device used to provide medication ... breathing and cannot achieve adequate oxygen levels to maintain ... asthma, COPD, and ARDS require the need of respiratory ...
(Date:7/29/2014)... July 29, 2014 Apex Medical Corporation (Apex, TWSE: ... Area Care sectors, announces that it is appealing the judgment ... in Germany that found the headgear ... that it has initiated invalidity challenges against various ResMed patents ... counterattacking against trivial and junk patents. ResMed ...
Breaking Medicine Technology:Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2Apex Continues Fighting Against Patents to Free Up Competition 2
... Ameritox (SM), the nation,s leader in Pain Medication Monitoring ... Record for the Congressional hearing on "Costs of Prescription ... to medication monitoring as a potential solution to improving ... in lowering national healthcare costs. The hearing was held ...
... /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH ... manufacturer and marketer of orthopedic implants in China, today ... 2011 financial results on November 9, 2011, after the ... conference call and live webcast at 8:00 a.m. ET ...
Cached Medicine Technology:Ameritox Supports Federal Implementation of Medication Monitoring for Chronic Pain Patients 2Ameritox Supports Federal Implementation of Medication Monitoring for Chronic Pain Patients 3China Kanghui Holdings to Report Third Quarter 2011 Financial Results 2
... FF 450plus Fundus Camera are reciprocally calibrated, ... and security that can't be approximated with ... level of integrated synergy, calibration and measurement ... pixel for pixel, the FF 450plus Fundus ...
... The VISULAS YAG III is the ... Meditec designed in particular for applications ... iridotomy. However, the YAG laser is ... and for IOL polishing. It's another ...
... The Afinion HbA1c test ... Analyzer, give you reliable facts ... you need them. Advising the ... with confidence. The HbA1c Test ...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
Medicine Products: